Author:
Adkins Douglas,Ley Jessica,Neupane Prakash,Worden Francis,Sacco Assuntina G,Palka Kevin,Grilley-Olson Juneko E,Maggiore Ronald,Salama Noha N,Trinkaus Kathryn,Van Tine Brian A,Steuer Conor E,Saba Nabil F,Oppelt Peter
Funder
National Cancer Institute
Reference31 articles.
1. GLOBOCAN 2012: Estimated cancer incidence, mortality and prevalence worldwide: IARC CancerBase No. 11;Ferlay,2014
2. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2016: a systematic analysis for the global burden of disease study;Fitzmaurice;JAMA Oncol,2018
3. Platinum-based chemotherapy plus cetuximab in head and neck cancer;Vermorken;N Engl J Med,2008
4. Open-Label, Uncontrolled, Multicenter Phase II Study to Evaluate the Efficacy and Toxicity of Cetuximab As a Single Agent in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Who Failed to Respond to Platinum-Based Therapy
5. Nivolumab for recurrent squamous-cell carcinoma of the head and neck;Ferris;N Engl J Med,2016
Cited by
94 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献